Vulto AG - Search Results

1

Inosine monophosphate dehydrogenase messenger RNA expression is correlated to clinical outcomes in mycophenolate mofetil-treated kidney transplant patients, whereas inosine monophosphate dehydrogenase activity is not.

Sombogaard F, Peeters AM, Baan CC, Mathot RA, Quaedackers ME, Vulto AG, Weimar W, van Gelder T. Sombogaard F, et al. Among authors: vulto ag. Ther Drug Monit. 2009 Oct;31(5):549-56. doi: 10.1097/FTD.0b013e3181b7a9d0. Ther Drug Monit. 2009. PMID: 19704402

2

Use of saliva in therapeutic drug monitoring of caffeine in preterm infants.

de Wildt SN, Kerkvliet KT, Wezenberg MG, Ottink S, Hop WC, Vulto AG, van Den Anker JN. de Wildt SN, et al. Among authors: vulto ag. Ther Drug Monit. 2001 Jun;23(3):250-4. doi: 10.1097/00007691-200106000-00011. Ther Drug Monit. 2001. PMID: 11360033

3

Optimal sampling strategies to assess inulin clearance in children by the inulin single-injection method.

van Rossum LK, Mathot RA, Cransberg K, Vulto AG. van Rossum LK, et al. Among authors: vulto ag. Clin Chem. 2003 Jul;49(7):1170-9. doi: 10.1373/49.7.1170. Clin Chem. 2003. PMID: 12816915 Clinical Trial.

4

Mycophenolic acid in diabetic renal transplant recipients: pharmacokinetics and application of a limited sampling strategy.

van Hest RM, Mathôt RA, Vulto AG, Le Meur Y, van Gelder T. van Hest RM, et al. Among authors: vulto ag. Ther Drug Monit. 2004 Dec;26(6):620-5. doi: 10.1097/00007691-200412000-00006. Ther Drug Monit. 2004. PMID: 15570185

5

Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation.

van Hest R, Mathot R, Vulto A, Weimar W, van Gelder T. van Hest R, et al. Ther Drug Monit. 2005 Apr;27(2):163-7. doi: 10.1097/01.ftd.0000158083.45954.97. Ther Drug Monit. 2005. PMID: 15795646

6

Estimation of the glomerular filtration rate in children: which algorithm should be used?

van Rossum LK, Mathot RA, Cransberg K, Zietse R, Vulto AG. van Rossum LK, et al. Among authors: vulto ag. Pediatr Nephrol. 2005 Dec;20(12):1769-75. doi: 10.1007/s00467-005-2001-y. Epub 2005 Aug 24. Pediatr Nephrol. 2005. PMID: 16133058

7

Population pharmacokinetics of mycophenolic acid in renal transplant recipients.

van Hest RM, van Gelder T, Vulto AG, Mathot RA. van Hest RM, et al. Among authors: vulto ag. Clin Pharmacokinet. 2005;44(10):1083-96. doi: 10.2165/00003088-200544100-00006. Clin Pharmacokinet. 2005. PMID: 16176120

8

Within-patient variability of mycophenolic acid exposure: therapeutic drug monitoring from a clinical point of view.

van Hest RM, Mathot RA, Vulto AG, Ijzermans JN, van Gelder T. van Hest RM, et al. Among authors: vulto ag. Ther Drug Monit. 2006 Feb;28(1):31-4. doi: 10.1097/01.ftd.0000194504.62892.b2. Ther Drug Monit. 2006. PMID: 16418690 Review.

9

Individualization of mycophenolate mofetil dose in renal transplant recipients.

van Hest RM, Hesselink DA, Vulto AG, Mathot RA, van Gelder T. van Hest RM, et al. Among authors: vulto ag. Expert Opin Pharmacother. 2006 Mar;7(4):361-76. doi: 10.1517/14656566.7.4.361. Expert Opin Pharmacother. 2006. PMID: 16503809 Review.

10

Pharmacokinetics of mycophenolate mofetil in hematopoietic stem cell transplant recipients.

van Hest RM, Doorduijn JK, de Winter BC, Cornelissen JJ, Vulto AG, Oellerich M, Löwenberg B, Mathot RA, Armstrong VW, van Gelder T. van Hest RM, et al. Among authors: vulto ag. Ther Drug Monit. 2007 Jun;29(3):353-60. doi: 10.1097/FTD.0b013e31805d8816. Ther Drug Monit. 2007. PMID: 17529894 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters